The neural retina is a logical target of gene therapy for highest degree of gene expression was obtained by various ocular diseases. We developed a new gene delivmethods A (23.2% of total retinal area) and C (19.8%), ery method to the neural retina using an adenoviral vector while the lowest degree was obtained by method B (8.9%). with a high degree of gene transfection efficiency and less
Introduction
Gene therapy has previously been considered as a treatment modality for various ocular diseases. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] In common retinal diseases such as diabetic retinopathy, proliferative vitreoretinopathy and glaucoma, the neural retina is a logical target for the transfer of genes for therapeutic purposes, because the neural retina is primarily damaged in most of these diseases and various attempts have been made to either protect or increase the healing of the neural retina. [3] [4] [5] 7, 9, 10 The adenoviral vector-mediated gene transfer to the retina can be classified into the following two groups, an extra-ocular injection or an intra-ocular injection. [1] [2] [3] [4] [5] [6] [7] [8] Cayoutte et al 7 reported that the injection of the adenoviral vector into the superior colluculus can deliver genes to the retinal ganglion cells, however, the brain is also transfected by this procedure and as a result, the procedure itself (namely, an injection into the brain) might induce more serious problems in the patients. Regarding intra-ocular injections, a subretinal injection can deliver genes to the retina but is limited to the retinal pigment epithelium of adult animals and the subretinal injection procedure itself sometimes induces apoptosis of photoreceptor cells. 1, 2, 6, 8 None the less, there is no established way to transfer genes to the neural retina efficiently and safely at present. The eye is an easily accessible organ thanks to current microsurgical techniques, and various gene transfer techniques can thus be performed.
A recombinant adenovirus has been used as an efficient in vivo vector to transfer genes into the adult eyes of experimental animals. [1] [2] [3] [4] [5] [6] [7] [8] This is because an adenoviral vector can transfer genes to nondividing cells with high efficiency. [1] [2] [3] [4] [5] [6] [7] [8] 11, 12 In spite of this advantage, there are still several problems concerning the use of an adenoviral vector, one of which is the possibility of inducing an inflammation due to the expression of viral proteins which might induce irreversible damage to the retinal 1089 function. 11, 12 There has yet to be a report which studies the function of the gene-transfected retina. To evaluate the retinal function, electroretinograms (ERGs) are often used in both the clinical field and in animal studies. An ERG records the electrical potential of the retina's response to light and it can thus directly detect the retinal function, and the components of ERG (eg a-wave or bwave) are also known to reflect the different elements of the retinal functions. 15 In the present study, the different gene transfection methods were studied regarding their gene transfection efficiency and functional safety. One of these methods could effectively transfer genes to the neural retina while avoiding any functional damage. This method may be a useful approach and can potentially be used for the transfer of genes in future clinical gene therapy.
Results
Gene transfer to the retina by different methods Gene transfer in retinochoroidal tissue was assessed by X-gal staining. The gene transfer efficiency was evaluated by measuring the X-gal-positive area on hemiflat mounted retinochoroidal tissue specimens and was expressed as the gene transfection efficiency index (GTEI). AdCALacZ (5 × 10 7 p.f.u./ml) was injected by the following methods: by method A (an intravitreal injection after an SF 6 gas compression vitrectomy followed by washing), the blue-colored areas (X-gal positive) were diffusely distributed in the neural retina. No massive hemorrhaging or retinal detachment was noticed ( Figure  1a ). The GTEI was 23.2 ± 9.2%. By method B (simple intravitreal injection), the X-gal-positive area was smaller than that by method A (Figure 1b) . In addition the GTEI was 8.9 ± 4.0% and it was significantly lower than that by method A (P Ͻ 0.05). By method C (intravitreal injection after SF 6 gas compression vitrectomy), the gene transfection was as good as by method A (Figure 1c ). The GTEI was 19.8 ± 5.1%, which was significantly higher than that by group B (P Ͻ 0.05). By method D (subretinal injection through the ora serrata with a microscalpel syringe with a 2 cm/30 gauge blunt needle), almost all areas exposed to an adenoviral vector were positively stained, but it was limited on the retinal pigment epithelial layer (Figure 1d , 52.1 ± 12.2% ). These results thus indicated that an SF6 gas vitrectomy increased the GTEI by almost two-fold (comparison of method B and method C, Figure 2a ).
The gene transfection efficiency index (GTEI) was also evaluated in the eyes injected with AdCALacZ of three different titers. The titers of an adenoviral vector were chosen based on the findings of our pilot study; which consisted of a high titer group 5 × 10 8 p.f.u./ml, middle titer group 5 × 10 7 p.f.u./ml and low titer group 5 × 10 6 p.f.u./ml. In each method, a minimal degree of gene transfer was observed with a low titer adenoviral vector. The high titer and middle titer adenoviral vector groups were almost the same for GTEI. These results are summarized in Figure 2b .
Histological examination
LacZ localization: By method A, the nuclei of the neural retinal cells showed positive reactions of X-gal staining ( Figure 3a) . By methods B and C, the neural retinal cells were positively stained and the nuclei of these cells were mainly located in the ganglion cell layer and partly in the outer nucleus layer (Figure 3b and c). RPE cells rarely stained positively. The ocular structure was well preserved by each method. By method D, the positively stained cells were limited to RPE cells and no neural retinal cells were positively stained (Figure 3d ). No eyes injected with BSS either subretinally or intravitreally were positively stained.
Immunohistochemistry: To specify the gene-transfected cells by an intravitreal injection, the specimens were examined immunohistochemically. The inner root of the gene-transfected cells was positively stained by antivimentin, antiglial fibrillary acidic protein (GFAP) and antiS100 protein antibodies (Figure 4 ).
Evaluation of inflammation:
Inflammatory cell infiltration was noticed in all eyes injected with an adenoviral vector and the results were expressed by the inflammatory cell infiltration index (ICII, number of inflammatory cells per microscopic field). The eyes with a BSS injection revealed either slight or no inflammation, which was much less than that of eyes with an adenoviral injection (data not shown), thus indicating that the injection procedures themselves did not cause the inflammation. The eyes injected with high titer AdCALacZ showed severe inflammatory cell infiltration (mainly mononuclear cells), and the inflammation was not significantly altered by each method (Figure 5a ). The middle titer adenoviral vector injection also induced ocular inflammation. The inflammation was the least severe by methods A and D, followed by methods B and C. The ICII by method A was significantly lower than that by methods B or C (P Ͻ 0.05, Figure 5b ). In the eyes injected with a low titer of AdCALacZ, the inflammation was less severe than in the eyes injected with either a middle or high titer of AdCALacZ. The eyes treated by method B or C tended to have a larger number of inflammatory cells (ICII) than in groups A and D, however, the inflammatory cell infiltrate was not significantly different from each method.
Electroretinograms (ERGs)
ERGs were performed to evaluate the functional changes of the retina caused by adenoviral vector-mediated gene transfer. The normal range of the ERG wave amplitude was obtained from a study of 70 normal rats without any treatment; dark-adapted a-wave 222.2 to 478.3 V, darkadapted b-wave 167.3 to 299.3 V, light-adapted b-wave 722.7 to 1435.3 V. The mean amplitudes of the dark-and light-adapted responses with an intravitreal or a subretinal injection of BSS were not significantly different from the eyes without any treatment (data not shown). Figure  6 shows the representative dark-and light-adapted (on a steady background field of 1.00 log cd/m 2 ) ERG waveforms of each group. The light adapted implicit times of the a-and b-waves did not significantly differ between each group. The amplitude of dark-and light-adapted ERGs are presented in Table 1 .
First, the influence of different gene delivery methods on the retinal function was studied. In this series, the middle titer (5 × 10 7 p.f.u./ml) adenoviral vectors were examined (Table 1) . By method A, the amplitudes of c b a d
Figure 1 The photographs of hemiflat mount retinochoroidal tissue treated with AdCALacZ on day 6 (observation from the vitreous side). (a) Method A, intravitreal injection of AdCALacZ after vitrectomy followed by washing; (b) method B, simple intravitreal injection of AdCAlacZ; (c) method C, simple intravitreal injection of AdCALacZ after gas vitrectomy; (d) subretinal injection of AdCALacZ. Each eye was injected with AdCALacZ and enucleated 4 days after injection. LacZ-positive area is visualized by X-gal staining (see the Materials and methods). The X-gal-positive blue-colored spots are noticed in the neural retina in groups A, B and C (A, B, C). The positive reaction is limited on the retinal pigment epithelial layer (d).
dark-adapted a-waves, dark-adapted b-waves and lightadapted b-waves were reduced, but they were still within the normal range. A significant reduction of the ERG amplitudes of all components was evident by methods B and C in comparison with the control eyes and the eyes with BSS injection (P Ͻ 0.05). The depression of the ERG amplitudes was the most significant by method C. The ERG change by method D was the same as that by method A. The normal range of the ERG amplitudes was obtained from 70 normal Wistar rats by our previous method;
16,17 a dark-adapted a-wave 222.2 to 478.3 V, a dark-adapted b-wave 722.7 to 1435.3 V, a light-adapted b-wave 167.3 to 299.3 V.
Second, the influence of different titers of adenoviral vector on the retinal function was studied, and both the high titer (5 × 10 8 p.f.u./ml) and low titer (5 × 10 6 p.f.u./ml) of AdCALacZ were used in method A. The results showed that a-and b-waves were distinctly found in all groups. In high-titer studies, the amplitudes of both the a-and b-waves were significantly reduced in comparison with those of the controls (P Ͻ 0.005). In lowtiter studies, the amplitudes of all waves were slightly reduced; however, they were all within the normal range ( Table 2 ).
Immunosuppressed animals
In order to see the effect of inflammation which is induced by AdCALacZ injection on the retinal function, the animals were treated with an intramuscular injection of cyclophosphamide and a subconjunctival injection of corticosteroid. Thereafter an AdCALacZ was injected into the eyes by method A and the ERG was recorded as described previously. The inflammatory cell infiltration was thus significantly inhibited by this treatment. The ICII by method A was 3.5 ± 1.2 cells per field. The ICII of animals with an intravitreal injection of BSS was 0.5 ± 0.2 cells per field. The ERG amplitude of darkadapted a-wave increased from 233 .3 to 288.6 V (23.7% increase), that of dark-adapted b-wave showed a 7% increase and light-adapted b-wave showed a 13.2% increase (Table 3) . These results thereafter indicated the ERG to be improved by inhibiting the inflammation after AdCALacZ injection.
Discussion
A simple injection of an adenoviral vector into the vitreous resulted in a modest gene transfection. 3 An adenovirus-mediated gene transfection depends on the direct contact of the virus with the recipient cells. 18 The vitreous body can be a large obstacle to direct contact between an adenovirus and the retina. In this study, we removed the vitreous body by an SF 6 compression gas vitrectomy to enhance the direct contact of an adenoviral vector to the retina. Consequently, this procedure improved gene transfer by approximately twice as much as by a simple injection. However, the inflammatory cell infiltration was still high (as seen in method C), and also damaged the retinal function. To solve this problem, the adenoviral vector was left in the vitreous for 30 min and was then washed out with BSS, as in method A. This method enabled a sufficient degree of gene expression and the inflammation was thus reduced. This procedure accomplished both an increased transfection efficiency while also decreasing the degree of decrease of inflammation. Currently, the vitrectomy is an established surgical technique and can be performed safely and reliably in clinical ophthalmology. Therefore, this gene transfer procedure (an injection of vector with both a vitrectomy and washing) is easily applicable to human eyes. On the other hand, a subretinal injection with an adenoviral vector could deliver genes much more efficiently to RPE cells than the other three methods, probably through direct contact with the cells in the subretinal space. RPE cells are supposed to play a key role in retinal degeneration so that this procedure may be suitable for the possible treatment of some forms of retinal degenerative diseases. A subretinal injection with a lentiviral vector and an adeno-associated viral vector can accomplish the high gene transfection efficiency as with an adenoviral vector. 19, 20 However, the experimental retinal detachment in cats, which was always generated with the present subretinal injection procedure, causes apoptosis of photoreceptor cells. 21 Therefore, intravitreal injection might be suitable to preserve the retinal function rather than subretinal injection; however, further study is necessary before clinical application.
The nuclei of the gene-transfected cells by intravitreal injection were located in the ganglion cell layer and these cells were positive immunohistochemically for antivimentin, anti GFAP and anti S100 protein antibodies. These cells are therefore primarily Mü ller cells. 22 However, photoreceptor cells were also transfected in part (Figure 3c) .
Although a high titer of adenoviral vector (5 × 10 8 p.f.u./ml) could transfer genes to the retina efficiently, it also induced moderate to severe inflammation in the eyes of all groups and a severe depression of the amplitudes of ERG. While a low titer of adenoviral vector induced only a slight degree of inflammation and little damage to ERG, the gene transfection efficiency was as low as 8.9% by the GTEI. An increased adenoviral titer has been reported to increase the gene transfection efficiency in a dose-dependent fashion. [1] [2] [3] In this study, however, the gene transfer did not improve substantially by increasing the injected adenoviral quantity from the middle to high titer, while the inflammation deteriorated to a greater extent. The gene transfection efficiency index thus improved from 29% (middle titer) to 31% (high titer), but the inflammatory cell infiltration index worsened from eight cells per field to 32 cells per field by method A. These results might be due to the inflammatory cell infiltration and the inflammatory reaction, including cytokine and complement production caused by the high titer of adenovirus, which hinders the transfection of adenoviral vector to the retina. The intra-ocular space is known as an immune-privileged site. In fact the transplanted tissue in the vitreous or the subretinal space did not produce an immune reaction, 23, 24 The intra-ocular inflammation related to the intra-ocular injection of an adenoviral vector might be weak and the retina thus seems to be an ideal site for the transfer of genes for therapeutic purposes. However, in this study, inflammation was indeed present although its extent varied, thus indicating that the intra-ocular space is not sufficiently immune privileged to adenoviral infection. Therefore, the proper titer of adenoviral vector should be used to achieve both efficient gene transfection and cause minimal damage to the retina. The adenoviral vector thus caused the ERG to a b c d
Figure 3 Histological findings of the retina treated by AdCALacZ. The cells of the neural retina were positively stained in the eyes treated by method A and the inflammatory cell infiltrate is observed in the neural retina or the vitreous (a). The neural retinal cells are also stained by method B (b) and ethod C (c). The retinal pigment epithelial cells stained positively, but the neural retinal cells showed no positive reaction in the eyes treated by method D (d). X-gal staining (original magnification: a, ×40; b and c, ×100; and d, ×60).
worsen in a dose-dependent manner by method A; however, the amplitudes of ERG were preserved within the normal range with 5 × 10 7 p.f.u./ml (1 l) or less of AdCALacZ.
The amplitudes of the ERG a-and b-waves were depressed in all eyes treated with an adenoviral vector. They decreased more in the eyes treated by methods B and C compared with those treated by methods A and D. The ERG changes closely correlated with the intensity of inflammation; the greater the inflammatory cell infiltration was, the more the amplitude of the ERG was decreased. In addition the depression of inflammation by corticosteroids and cyclophosphamide increased the ERG amplitude of AdCALacZ-injected eyes. Hence, the present retinal functional changes could, at least in part, be caused by inflammation after adenoviral-vector injection. Our results also indicated ERGs to be a good indicator for monitoring the retinal functional changes after adenoviral gene transfection. It should be noted that the ERG examination caused little or no damage to the eye and it can also be done repeatedly on the same eye. Others also reported the ERG to be more sensitive than clinical and histological evaluations. In addition, it can also detect any subtle alterations of the retina before inflammation develops. 25 Even though inflammation of the adenovirus-injected eyes was either minimal or absent and the histological study did not show any apparent damage in these eyes, the ERG amplitudes were often depressed. This finding implies that the insertion of exogenous gene itself can change the retinal function unexpectedly without showing any apparent morphological alterations. Gene transfer to the retina for therapeutic purposes may therefore be a good idea, because the trivial change of the microenvironment by gene transfection might effectively improve the retinal function; however, on the other hand gene transfer may also induce some unexpected functional changes in the retina. Based on these findings, functional assessment such as measuring the ERG, should be performed in future gene therapy.
In conclusion, the intravitreal injection with an adenoviral vector after a vitrectomy followed by washing is considered to be an efficient and safe method for transferring genes to neural retinal cells. Although further a c b
Figure 5 Inflammation index. The inflammation index was assessed as described in the Materials and methods. (a) The inflammation index assessed for the eyes treated with middle titrated AdCALacZ. (b) The inflammation index for the eyes treated with three different titers of AdCALacZ. (a) Methods B and C showed a significantly higher inflammation index (*, P Ͻ 0.05). High titrated AdCALacZ had a stronger inflammation index than middle or low titrated inflammation index (b).
detailed studies are required before clinical trials can be done especially with respect to the late onset immunoreaction, the present procedure using an adenoviral vector may be an efficient way to transfer genes into the retina for the treatment of various ocular diseases.
Materials and methods

Animals
Wistar rats weighing 200 to 250 g (8 weeks old, Kyudo, Fukuoka, Japan) were used. All animals were used The ERG amplitudes of eyes treated by method A were significantly higher than in the indicated groups (*, P Ͻ 0.05). humanely, with the proper institutional approval, and in compliance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.
Adenoviral vector
A replication-defective E1 − and E3 − recombinant adenoviral vector expressing bacterial ␤-galactosidase under a CA promoter that was composed of cytomegalovirus enhancer and chicken ␤-actin promoter (AdCALacZ) was previously described. 16, 17, 26, 27 AdCALacZ was purified by ultracentrifugation through a CsCl 2 gradient followed by extensive dialysis. The titer of the virus stock was assessed by a plaque formation assay using 293 cells and expressed as plaque formation units (p.f.u.). All manipulations of adenoviral vectors were done in accordance with both institutional and national biosafety restrictions.
Four different methods of gene delivery to the retina AdCALacZ was delivered to the retina by four different methods. Each surgical procedure was performed by surgical microscopy. At first (method A, n = 35), a vitrectomy was performed by expanding gas injection (SF 6 ). The injected gases expanded approximately 2.4-fold and made a vitreous-free space in the vitreous.
28 SF 6 was injected by a Hamilton syringe with a blunt 30 G needle 1 and 2 weeks before surgery (3-5 l per eye). Next BSS containing adenoviral vector (BSS-ad, 1 l) was injected into the vitreous and incubated for 30 min. A 30 G needle was inserted into the vitreous through the other side of the pars plana for drainage and then the vitreous space was washed out with 1 ml BSS gently to remove the nontransferred adenoviral vector. In the second group (method B, n = 20), BSS-Ad (1 l) was also injected into the rat vitreous using a Hamilton syringe with a blunt 30 G needle. In the third group (method C, n = 20), BSS-Ad (1 l) was injected into the vitreous after SF 6 gas vitrectomy and then the eyes were examined. In the fourth group (method D, n = 20), BSS-Ad, 1 l was injected into the subretinal space by the previously described method with some modifications. 1 Briefly, after making an incision behind the ora serrata with a microscalpel, a Hamilton syringe with a 2 cm/30 G blunt needle was inserted tangentially toward the back of the eye. The subretinal delivery was confirmed by the appearance of a partial retinal detachment. All the subretinally BSS-adinjected eyes showed a transient bullous retinal detachment over more than half the retinal area. Without any additional treatment, the detached retina gradually settled down and was then reattached by 3 days after the treatment. The influence of different titers of adenoviral vectors (5 × 10 8 , 5 × 10 7
, 5 × 10 6 p.f.u./ml) was also examined by these four methods. Our preliminary study showed that an SF6 gas vitrectomy by the intravitreal gas injection procedure did not induce any significant electroretinographical or morphological changes of the retina (data not shown). The eyes without any treatment were used as negative controls. The eyes with an intravitreal gas vitrectomy and subsequent injection of BSS were also used as controls. The eyes with subretinal injection of BSS were used as controls for subretinal adenoviral injection. All procedures were performed in an air-conditioned room and all solutions used in these procedures were at room temperature (22 ± 2°C).
Gene transfer efficiency index
The gene transfer efficiency was evaluated by our previously described method with some modifications. 10 Briefly, the rats were killed and the eyes were enucleated and then processed for a histochemical evaluation. The eyes were fixed in 0.5% glutaraldehyde in phosphatebuffered saline (PBS) for 1 h at room temperature. The anterior segments and the lens were removed, and the eye cups were incubated at room temperature for 2 h in a solution of 5 mm K 3 Fe(CN) 6 , 5 mm K 4 Fe(CN) 6 , 2 mm MgCl 2 , 1 mg/ml 5 bromo-4-chloro-3-indolyl-␤-d-galactoside (X-gal) in PBS at pH 7.8. After staining for ␤-galactosidase activity, the eye cups were post-fixed in 2.5% glutaraldehyde and 1% formaldehyde in 0.1 m sodium cacodylate buffer (pH 7.0) for 1 h or longer and placed in 4% paraformaldehyde for 12 h. Then the vitreous was also removed by forceps and scissors and thus the remaining tissue was composed of the retina, choroid and sclera. The tissue specimens were divided with a razor blade and placed on a glass slide in a semiflat mount manner into quarters. The tissue was photographed and then the ␤-galactosidase-positive area (blue color) and total retinal area (including choroid and sclera) were measured by an NIH image analyzer. The ratio of lacZ-positive area/total retinal area was expressed as a percentile and the gene transfer efficiency was evaluated by the gene transfection efficiency index (GTEI).
Histological examination
LacZ localization: X-gal staining was performed to visualize ␤-galactosidase in the same way as described in the previous section. The fixed and X-gal-reacted eyes were then embedded in paraffin and 5 m sections were made. After that these sections were counterstained with neutral red and examined under light microscopy.
Histological evaluation for the inflammatory cell infiltration index: The five eyes of each group were randomly chosen and the paraffin-embedded section (5 m thick) was routinely stained by hematoxylin and eosin. The 20 different pictures of retinochoroidal tissue of each eye (magnification, ×40) were randomly photographed and projected on the screen. The number of inflammatory cells in a single picture was counted by masked observers and expressed as the inflammatory cell infiltration index (cells per field).
Immunohistochemistry: X-gal staining was performed to visualize ␤-galactosidase in the same way as described in the previous section. The fixed and X-gal-reacted eyes were then embedded in paraffin and 5 m sections were made. Then an immunohistochemical study was performed by the routine avidin-biotin peroxidase complex method. 9 Antivimentin antibody (rabbit, polyclonal; Dakopatts, Glostrup, Denmark), antiGFAP antibody (rabbit, polyclonal; Dakopatts) and antiS100 protein antibody (goat, polyclonal; Sigma, St Louis, MO, USA) were used and the sections were all counterstained by hematoxylin.
Electroretinograms (ERGs)
The ERG was recorded by a masked examiner without any information on the treated or nontreated animals. Each animal was used for the ERG study at a single timepoint. The rats were kept in a dark room at least overnight before the experiment. The electroretinographical evaluations were performed as previously described. 17, 26 The rats were anesthetized with an intraperitoneal injection of 15 ml/g body weight of saline solution containing katamine (1 mg/ml), myoblock (0.4 mg/ml), and urethane (40 mg/ml). Both pupils were dilated with mydrin (2.5% phenylephrine HCl and 0.5% tropicamide content; Santen, Osaka, Japan), and the animals were placed on a heating pad. ERGs were recorded using a coiled stainless steel wire containing the anesthetized (1% proparacaine HCl) corneal surface through a layer of 1% methylcellulose, 29,30 and a similar wire was also placed in the leads, respectively. The responses were differentially amplified (band pass; 0.8 to 1200 Hz), averaged and stored using a PC9801 computer (NEC, Tokyo, Japan). Xenon strobe flash stimuli (t Ͻ 1 ms) were presented in a Ganzfeld stimulator (VPA-10; Cadwell, Kennewick, WA, USA), either in the dark or superimposed on an adapting field.
The ERGs were recorded in two sessions. The darkadapted response was obtained using a flash intensity of 1.30 log cd-s/m 2 . The responses to five successive flashes in each rat were averaged. In addition, a minute interflash interval was used for this session. The animals were then exposed to a 1.00 log cd/m 2 achromatic-adapting field luminance and after a period of 20 min during which responses reached a stable amplitude, light adapted 2 Hz ERGs were recorded using flash intensity 1.30 log cd-s/m 2 . In each rat, the responses to 50 successive flashes were averaged.
Immunosuppressed animals AdCALacZ (5 × 10 7 p.f.u.) was injected into the rat eyes by method A and the animals were treated with an intramuscular injection of cyclophosphamide (0.2 mg/g, Sigma) and a subconjunctival injection of corticosteroid (0.5 mg per rat, dexamethasone; Sigma) on days 0, 3 and 5. 31 The ERG was recorded on day 6, as described previously. The animals received a BSS injection by method A, which was the same as that used in the control. The inflammatory cell infiltration was evaluated by the method described in the previous section.
Statistical analysis
Differences in the amplitudes among the experimental groups were analyzed using the Kruskal-Wallis test and the Wilcoxon rank-sum test. Differences in the GTEI and the inflammatory index were also analyzed by the Wilcoxon rank-sum test. A P value of less than 0.05 was considered to be statistically significant.
